Franck Madoux
Associate Director, Amgen
Franck Madoux is listed as Associate Director, Amgen. Franck is scheduled to speak at SLAS 2027 International Conference & Exhibition on 30 January 2027.
Compiled from published conference agendas; not yet confirmed by Franck. Is this you? Claim this profile.
About
Franck Madoux, Ph.D., is an Associate Director at Amgen, where he leads the Automated Screening Platform (ASP) team to support small molecule drug discovery. With over 20 years of experience across small-biotech, academia and industry, he has managed advanced screening platforms and workflows at the intersection between automation, novel detection technologies and data analytics to accelerate lead identification and optimization. Prior to Amgen, Franck worked at the Scripps Research Institute, where he executed numerous large-scale high-throughput screening campaigns and helped pioneer physiologically relevant assay systems such as 3D spheroids and high-content imaging in the miniaturized 1536-well plate format. His work has included assay development, miniaturization, and execution for hundreds of ultra-high-throughput screening campaigns. He has co-authored peer-reviewed publications in drug discovery and chemical biology. He is an active member of the SLAS community, having served a
Upcoming
SLAS 2027 International Conference & Exhibition 30 January 2027 – 3 February 2027
Announced as a speaker.